Vivesto AB (STO:VIVE)
Sweden · Delayed Price · Currency is SEK 0.0828
+0.0018 (2.22%)
At close: Mar 2, 2026
Vivesto AB Market Cap
Vivesto AB has a market cap or net worth of 91.67 million as of March 2, 2026. Its market cap has decreased by -27.03% in one year.
Market Cap
91.67M
Enterprise Value
90.21M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.08
Market Cap Chart
Since August 11, 2006, Vivesto AB's market cap has decreased from 1.15B to 91.67M, a decrease of -92.04%. That is a compound annual growth rate of -12.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 89.68M | 23.46% |
| Dec 30, 2025 | 72.64M | -53.45% |
| Dec 30, 2024 | 156.03M | -28.83% |
| Dec 29, 2023 | 219.25M | -6.11% |
| Dec 30, 2022 | 233.51M | -80.14% |
| Dec 30, 2021 | 1.18B | -36.33% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EQL Pharma AB | 1.71B |
| Orexo AB | 990.58M |
| Cinclus Pharma Holding AB | 811.62M |
| Nanexa AB | 655.87M |
| Dicot Pharma AB | 599.79M |
| Moberg Pharma AB | 486.46M |
| Enzymatica AB | 475.76M |
| Klaria Pharma Holding AB (publ.) | 201.21M |